Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
Axon Enterprise (AXON) Holds Steady Near $426 After a Volatile Month

Axon Enterprise (AXON) Holds Steady Near $426 After a Volatile Month

Key Takeaways

  • AXON shares were essentially flat over the past 30 days, moving roughly +0.3% from a closing level near $424.75 to about $425.87, despite meaningful intraday volatility during the period.
  • The flat 30-day move contrasts with a deeper drawdown: the stock remains down roughly 30% year-to-date and about 43% over the past year amid a broader software-sector valuation reset.
  • Underlying fundamentals remain robust, with second-quarter 2026 revenue of about $904 million (up roughly 35% year over year), annual recurring revenue near $1.6 billion, and net revenue retention of 126%.
  • Key near-term catalysts include the company's third-quarter 2026 earnings report, scheduled for release on November 5, 2026, and continued traction in AI-enabled software and counter-drone offerings.
  • Analyst sentiment remains broadly constructive, with a consensus Strong Buy rating and an average price target well above recent trading levels, even as several firms have trimmed individual targets.
  • For additional detail on valuation and expectations, explore Axon's Price Targets, Earnings, and Forecast pages.

Current Market Snapshot

Axon Enterprise shares traded near $425 in late October 2026, roughly unchanged from a month earlier. The stability of the trailing-30-day window masks a choppier path: the stock declined from the mid-$450s in late September toward the $380s by mid-October before rebounding. That intraday range reflects lingering investor caution rather than a decisive directional move. I also checked this using Tickeron’s AI Trend Prediction Engine to see how the stock compares to others in the industry.

The broader context is more telling. Even after recovering from its recent lows, Axon remains well below its 2025 peak and has underperformed a software sector that has largely rebounded in 2026. The company now carries a market capitalization of roughly $34 billion, with a price-to-sales multiple that has compressed sharply from its earlier highs. This combination—solid operating momentum alongside a meaningful de-rating—defines the current narrative for AXON.

Axon Enterprise (AXON) Business Overview and Competitive Position

Axon Enterprise, Inc. is the global leader in public safety technology, serving state, local, federal, and international agencies as well as a growing enterprise market. The company's ecosystem spans hardware and software, anchored by its TASER conducted-energy devices, body-worn and in-car cameras, and the Axon Evidence cloud platform for managing digital evidence.

Axon has expanded well beyond its original device franchise. Its portfolio now includes the AI-enabled Axon Era Plan, generative reporting tools such as Draft One, the Axon Assistant productivity suite, the Fusus real-time crime-center platform, Dedrone counter-drone technology, and emerging 911 solutions. This hardware-plus-software model generates durable, recurring revenue through long-term subscription contracts, which investors follow closely because of its high visibility and compounding growth.

Competitive strengths include deep integration across the public-safety workflow, high customer switching costs, a track record of innovation, and an expanding international and enterprise footprint. Founder-led since 1993, Axon has positioned itself as a mission-critical technology provider where trust, security, and reliability are central to customer adoption.

Recent Developments Driving AXON

Several verified developments shaped Axon's recent trading. In August 2026, the company reported second-quarter revenue of approximately $904 million, up about 35% year over year and ahead of consensus, though non-GAAP earnings per share of $1.88 narrowly missed estimates. Management subsequently raised its full-year revenue outlook to 32%–34% growth while maintaining an adjusted EBITDA margin target of about 25.5%.

Product momentum continued to accelerate. AI product revenue grew more than 700% year over year in the first quarter, and management highlighted rapid adoption of the AI Era Plan alongside strength in Dedrone, which surpassed $100 million in quarterly revenue after supporting U.S. World Cup stadiums. At the 2026 IACP conference, Axon unveiled its Axon Body 5 camera, pairing upgraded AI processing with deeper software integration.

At the same time, sentiment was tempered by valuation and margin concerns. A $1 billion convertible notes offering, a lower cash-flow outlook tied to an investment cycle, and gross-margin pressure from tariffs, memory costs, and product mix all weighed on the shares. Analyst actions reflected this tension: UBS initiated coverage with a Hold rating and a $470 target, while Raymond James and TD Cowen lowered their price targets to $675 and $800, respectively, while maintaining constructive ratings.

2026 Outlook and What Investors Should Watch

Looking ahead, Axon's third-quarter earnings report on November 5, 2026, is the most immediate catalyst. Investors will focus on revenue growth against the company's raised 32%–34% guidance, adjusted EBITDA margins, free-cash-flow conversion, and any update on the full-year outlook. Management has signaled that Q3 could be seasonally soft before a stronger fourth quarter, so commentary on the demand pipeline will be closely scrutinized.

Beyond earnings, key themes include the durability of AI and counter-drone growth, international expansion, and the pace of enterprise adoption. Margin recovery will depend on memory costs, tariff exposure, and product mix, while investor confidence may hinge on the company demonstrating improving cash-flow conversion as it scales newer businesses. Macroeconomic conditions, government budget cycles, and competitive dynamics in public-safety technology remain important external factors. These elements, rather than short-term price swings, will likely shape AXON's trajectory through 2026. From what I see, I’m watching this closely for signs of sustained momentum.

Using Tickeron AI Tools for Deeper Analysis

In my view, one practical way to complement traditional research is with Tickeron’s Trending AI Robots. The page highlights top-performing automated strategies across hundreds of bots that monitor thousands of tickers. Each bot differs in strategy, timeframe, and performance metrics, allowing users to evaluate approaches aligned with their own objectives and risk tolerance. It serves as a useful starting point for exploring how algorithmic signals can fit alongside fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXON

AXON's RSI Indicator descends into oversold zone

The RSI Indicator for AXON moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 270 of 367 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 52 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -16%. For the same Industry, the average monthly price growth was -17%, and the average quarterly price growth was -35%. POWW experienced the highest price growth at 13%, while VWAV experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 41%. For the same stocks of the Industry, the average monthly volume growth was 16% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 53
Price Growth Rating: 65
SMR Rating: 78
Profit Risk Rating: 79
Seasonality Score: -14 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry AerospaceDefense

Industry
Biotechnology
Address
17800 North 85th Street
Phone
+1 480 991-0797
Employees
6300
Web
https://www.axon.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.